Dispensed: Prescribing guidelines at a buzzy men's health startup, a depression drug moves one step closer to approval, and a leaked letter that's fueling a fight over high drug prices

9:05am PST - February 15th, 2019    ketamine - Business Insider

Hello, This week was busy with a big M&A deal for a surgical robotics company and lackluster results for the super-hot, $35 billion NASH market. But in between the breaking news, here were the stories that caught our attention this week. New to our weekly new…